{
	"kja6ivprText": "Brintellix® (n=2,694)",
	"kja6ivpsText": "Placebo (n=1,522)",
	"kja6ivptText": "F<span class=\"_ _c\"></span>lore<span class=\"_ _c\"></span>a I et al. 2<span class=\"_ _c\"></span>0<span class=\"_ _c\"></span>1<span class=\"_ _23\"></span>7<span class=\"_ _3\"></span><span class=\"fs1 v1\">1</span>",
	"kja6ivpuText": "<div style=\"line-height: 1.2;\">Meta-analysis of nine short-term (6/8 week), multicentre, double-blind, randomised,<br>placebo-controlled, parallel-group, fixed dose clinical studies of Brintellix® in adult<br><span class=\"ls2e ws10\">patients with MDD.</span></div><div style=\"line-height: 1; margin-top:5px;\">Study objective: <span class=\"ff3\">Assess the effect of Brintellix® on overall functioning (primary) and  \nfunctional remission (secondary) using the Sheehan Disability Scale (SDS) in adults with MDD.</span></div>",
	"kja6ivpvText": "Ke<span class=\"_ _2\"></span>y inclusion cri<span class=\"_ _0\"></span>teria for t<span class=\"_ _0\"></span>he nine shor<span class=\"_ _0\"></span>t-term<span class=\"_ _0\"></span> st<span class=\"_ _0\"></span>udies ",
	"kja6ivpwText": "• Sev<span class=\"_ _2\"></span>ere d<span class=\"_ _2\"></span>epr<span class=\"_ _2\"></span>ession<span class=\"_ _c\"></span>: MADRS ≥2<span class=\"_ _2\"></span>2 (<span class=\"_ _c\"></span>s<span class=\"_ _0\"></span>tudie<span class=\"_ _2\"></span>rs enr<span class=\"_ _2\"></span>oll<span class=\"_ _2\"></span>ed patie<span class=\"_ _2\"></span>nts with base<span class=\"_ _2\"></span>line M<span class=\"_ _2\"></span>ADRS 22<span class=\"_ _3\"></span>-30)",
	"kja6ivpxText": "• MDE ≥<span class=\"_ _2\"></span>3 ",
	"kja6ivpyText": "• CG<span class=\"_ _2\"></span>I-S &gt;4<span class=\"_ _c\"></span>*",
	"kja6ivpzText": "<div style=\"text-align: center;\">A random-<span class=\"_ _0\"></span>ef<span class=\"_ _0\"></span>fec<span class=\"_ _0\"></span>t<span class=\"_ _0\"></span>s,</div><div style=\"text-align: center;\">aggregated, s<span class=\"_ _0\"></span>tudy-level</div><div style=\"text-align: center;\"><span style=\"text-align: start;\">meta-analysis was per</span><span class=\"_ _0\" style=\"text-align: start;\"></span><span style=\"text-align: start;\">formed</span><br></div><div style=\"text-align: center;\"><span style=\"text-align: start;\">using d</span><span class=\"_ _2\" style=\"text-align: start;\"></span><span style=\"text-align: start;\">ata for all t</span><span class=\"_ _2\" style=\"text-align: start;\"></span><span style=\"text-align: start;\">herapeuti</span><span class=\"_ _2\" style=\"text-align: start;\"></span><span style=\"text-align: start;\">c</span><span style=\"text-align: start;\"><br></span></div><div style=\"text-align: center;\"><span style=\"text-align: start;\">doses of Brintellix®</span><span style=\"text-align: start;\"><br></span></div>",
	"kja6ivq4Text": "Nine short-term <br>(6/8 week), placebo-<br>controlled studies:<span class=\"fs1b ls34 ws72 v8\">2-10</span><span class=\"ls5\"> </span>",
	"kja6ivq5Text": "• Baldwin DS et al. 2012. <br>• Henigsber<span class=\"_ _c\"></span>g N et al. 2012. <div>• Boulenger J et al.<span class=\"_ _2\"></span>&nbsp;2014.&nbsp;<br>• Mahableshwarkar AR et al.<span class=\"_ _c\"></span>&nbsp;2015.<br></div><div>• Jacobsen PL<span class=\"_ _2\"></span>&nbsp;et al. 2015.&nbsp;<br><span class=\"ws78\">• T<span class=\"_ _3\"></span>akeda 2013.</span><br></div><div><span class=\"ws78\">• Jain R et al.<span class=\"_ _2\"></span>&nbsp;2013.&nbsp;<br><span class=\"ws79\">•&nbsp;<span class=\"_ _1\"></span>Mahableshwarkar&nbsp;<span class=\"_ _24\"></span>AR&nbsp;<span class=\"_ _1c\"></span><span class=\"_ _25\"></span><span class=\"_ _25\"></span><span class=\"_ _25\"></span><br></span>&nbsp;&nbsp;&nbsp;et al. 2013 .&nbsp;<br><span class=\"ws43\">• Mahableshwarkar AR,<span class=\"_\">&nbsp;</span><br></span>Serenko M et al.<span class=\"_ _c\"></span>&nbsp;2015.<br></span></div>",
	"kja6ivq9Text": "<div style=\"line-height: 1.3;\"><div style=\"text-align: center;\">Assessments:</div><div style=\"text-align: center;\">Functional<br style=\"\"></div><div style=\"text-align: center;\"><span style=\"text-align: start;\">impairment as</span><br></div><div style=\"text-align: center;\"><span style=\"text-align: start;\">assessed by the</span><span style=\"text-align: start;\"><br style=\"\"></span></div><div style=\"text-align: center;\"><span style=\"text-align: start;\">Sheehan Disability</span><span style=\"text-align: start;\"><br style=\"\"></span></div><div style=\"text-align: center;\"><span style=\"text-align: start;\">Scale (SDS)</span><span style=\"text-align: start;\"><br style=\"\"></span></div></div>",
	"kja6ivqfText": "Back",
	"kja6ivqgText": "*Boulenger J et al. 2014.<span class=\"_ _c\"></span> Mahableshwarkar AR et al. 2015. <span class=\"_ _2\"></span>Jacobsen PL et al.<span class=\"_ _2\"></span> 2015. <span class=\"_ _2\"></span>T<span class=\"_ _c\"></span>akeda 2013 and Mahableshwarkar AR, Ser<span class=\"_ _2\"></span>enko M et al.<span class=\"_ _2\"></span> 2015 only.",
	"Brintellix_727563fcb9": "<span class=\"ff2 fc0 fs13\">References</span>",
	"Brintellix_72eead1026": "<div class=\"ff3 fc1\" style=\"font-size:15px;\"><span class=\"ff2\">1.</span> Florea I et al. Brain Behav 2017;7:e00622.</div>"
}
